Vial is a contract research organization that enables scientists to reach those interested and in need of clinical treatment trials for a broad range of diseases and health disorders. Vial networks with engineers, product managers, and designers from silicon valley, and combines that expertise with scientists needing to reach individuals for possible future studies. In addition to these study needs, Vial also connects scientists and healthcare organizations with sponsors for their clinical programs.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/30/2022 | Series B-2 | $67MM | $xx.xx | $79.92B | Boxgroup, Byers Capital, General Catalyst | |
Price per Share
$xx.xx
Shares Outstanding
21,836,886
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Boxgroup, Byers Capital, General Catalyst
|
||||||
09/15/2021 | Series B-1 | $249,996.00 | $xx.xx | $10.29B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
670,380
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/15/2021 | Series B | $34.63MM | $xx.xx | $10.29B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
79,953,170
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/15/2021 | Series A-2 | $39,999.00 | $xx.xx | $6.26B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
988,240
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/15/2021 | Series A-3 | $399,999.00 | $xx.xx | $6.26B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,353,290
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/15/2021 | Series A-1 | $824,995.00 | $xx.xx | $6.26B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
10,191,420
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/15/2021 | Series A | $6MM | $xx.xx | $6.26B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
14,645,530
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|